These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 7536649)
1. Localization of the complement membrane attack complex inhibitor (CD59) in human conjunctiva and lacrimal gland. Bardenstein DS; Dietz Y; Lass JH; Medof ME Curr Eye Res; 1994 Dec; 13(12):851-5. PubMed ID: 7536649 [TBL] [Abstract][Full Text] [Related]
2. Cell surface regulators of complement, 5I2 antigen, and CD59, in the rat eye and adnexal tissues. Bardenstein DS; Cheyer C; Okada N; Morgan BP; Medof ME Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):519-24. PubMed ID: 9950613 [TBL] [Abstract][Full Text] [Related]
3. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland. Lass JH; Walter EI; Burris TE; Grossniklaus HE; Roat MI; Skelnik DL; Needham L; Singer M; Medof ME Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1136-48. PubMed ID: 1693916 [TBL] [Abstract][Full Text] [Related]
4. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin). Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736 [TBL] [Abstract][Full Text] [Related]
5. Time-dependent loss of surface complement regulatory activity during storage of donor blood. Long KE; Yomtovian R; Kida M; Knez JJ; Medof ME Transfusion; 1993 Apr; 33(4):294-300. PubMed ID: 7683151 [TBL] [Abstract][Full Text] [Related]
6. Identification of the complement regulatory proteins CD46, CD55, and CD59 in human fallopian tube, endometrium, and cervical mucosa and secretion. Jensen TS; Bjørge L; Wollen AL; Ulstein M Am J Reprod Immunol; 1995 Jul; 34(1):1-9. PubMed ID: 7576125 [TBL] [Abstract][Full Text] [Related]
8. Complement regulatory proteins in early human fetal life: CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver. Simpson KL; Houlihan JM; Holmes CH Immunology; 1993 Oct; 80(2):183-90. PubMed ID: 7505254 [TBL] [Abstract][Full Text] [Related]
9. Localization of the complement regulatory proteins in the normal human kidney. Ichida S; Yuzawa Y; Okada H; Yoshioka K; Matsuo S Kidney Int; 1994 Jul; 46(1):89-96. PubMed ID: 7523758 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of complement regulatory proteins decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 during human spermatogenesis. Simpson KL; Holmes CH Immunology; 1994 Mar; 81(3):452-61. PubMed ID: 7515850 [TBL] [Abstract][Full Text] [Related]
11. Release of complement regulatory proteins from ocular surface cells in infections. Cocuzzi E; Guidubaldi J; Bardenstein DS; Chen R; Jacobs MR; Medof EM Curr Eye Res; 2000 Nov; 21(5):856-66. PubMed ID: 11262607 [TBL] [Abstract][Full Text] [Related]
12. The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues. Thorsteinsson L; O'Dowd GM; Harrington PM; Johnson PM APMIS; 1998 Sep; 106(9):869-78. PubMed ID: 9808413 [TBL] [Abstract][Full Text] [Related]
13. Distribution of complement regulators (CD46, CD55 and CD59) in skin appendages, and in benign and malignant skin neoplasms. Sayama K; Shiraishi S; Miki Y Br J Dermatol; 1992 Jul; 127(1):1-4. PubMed ID: 1379063 [TBL] [Abstract][Full Text] [Related]
14. A simplified assay for the specific diagnosis of paroxysmal nocturnal hemoglobinuria: detection of DAF(CD55)- and HRF20(CD59)- erythrocytes in microtyping cards. Nilsson B; Hagström U; Englund A; Säfwenberg J Vox Sang; 1993; 64(1):43-6. PubMed ID: 7680511 [TBL] [Abstract][Full Text] [Related]
15. Protection of germinal centres from complement attack: decay-accelerating factor (DAF) is a constitutive protein on follicular dendritic cells. A study in reactive and neoplastic follicles. Lampert IA; Schofield JB; Amlot P; Van Noorden S J Pathol; 1993 Jun; 170(2):115-20. PubMed ID: 7688416 [TBL] [Abstract][Full Text] [Related]
16. Expression of the DAF (CD55) and CD59 antigens during normal hematopoietic cell differentiation. Terstappen LW; Nguyen M; Lazarus HM; Medof ME J Leukoc Biol; 1992 Dec; 52(6):652-60. PubMed ID: 1281489 [TBL] [Abstract][Full Text] [Related]
17. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis. Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964 [TBL] [Abstract][Full Text] [Related]
18. Levels of complement regulatory molecules in lung cancer: disappearance of the D17 epitope of CD55 in small-cell carcinoma. Sakuma T; Kodama K; Hara T; Eshita Y; Shibata N; Matsumoto M; Seya T; Mori Y Jpn J Cancer Res; 1993 Jul; 84(7):753-9. PubMed ID: 7690355 [TBL] [Abstract][Full Text] [Related]
19. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis. Brooimans RA; van Wieringen PA; van Es LA; Daha MR Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224 [TBL] [Abstract][Full Text] [Related]
20. Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers. Navenot JM; Villanova M; Lucas-Héron B; Malandrini A; Blanchard D; Louboutin JP Muscle Nerve; 1997 Jan; 20(1):92-6. PubMed ID: 8995588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]